SAN FRANCISCO – July 10, 2023 – Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 32,500,000 shares of its common stock at a public offering price of $0.055 per share. Gross proceeds from the […]
SAN FRANCISCO – July 7, 2023 – Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it intends to offer and sell shares of its common stock in a public offering. All of the shares of common stock are being offered by Tivic. […]
SAN FRANCISCO – June 27, 2023 – Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that the Company has entered into a non-exclusive distribution agreement with Cardinal Health (RGH Enterprises) for Tivic’s products. Cardinal Health is a leading distributor and manufacturer of medical products and services […]
SAN FRANCISCO – June 15, 2023 – Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that the company is expanding its target market for ClearUP to the vast population of consumers with allergy and congestion-related issues who are deprived of sleep, exercise, and concentration. A recent Tivic […]
Tivic to Reconvene Annual Meeting of Stockholders June 14, 2023 Tivic urges shareholders of record as of April 13, 2023, to vote their shares. SAN FRANCISCO – June 9, 2023 – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that its 2023 […]
Tivic Reports First Quarter 2023 Financial Results Gross Profit Increase by 61.3%; extends innovation pipeline to include vagus nerve stimulation. SAN FRANCISCO – May 15, 2023 – Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, is pleased to announce its financial results for the first […]
SAN FRANCISCO – May 11, 2023 – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the first quarter 2023 via a pre-recorded conference call and webcast on Monday, May 15th, 2023 at 1:30 pm PT / 4:30 pm ET. […]
SAN FRANCISCO – May 8, 2023 – Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has launched a B2B portal to support its increasing demand for commercial ordering of its doctor recommended and FDA-approved bioelectronic sinus device, ClearUP. This portal is available to pharmacy groups and […]
SAN FRANCISCO – May 1, 2023 – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the appointment of veteran Kimberly Bambach to serve as Interim Chief Financial Officer of the company and the engagement of Christina Valauri as a strategic advisor to the […]
Opportunity for Bioelectronic Medicine to Reduce Dependence on Opioids SAN FRANCISCO – April 19, 2023 – Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has expanded its post-operative pain clinical study to include Otolaryngology and Facial Plastic Surgery patients. This study aims to investigate the potential […]
